| LINE ITEM (USD / %) | FY 2025
FILED 2026-05-31 | FY 2024
FILED 2025-05-31 | FY 2023
FILED 2024-05-31 |
|---|---|---|---|
| Revenue (Total Sales) | $94.72B | $87.93B | $87.69B |
| YoY Revenue Growth % | +7.7% | +0.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $5.46B | $5.22B | $5.56B |
| Operating Margin % | 5.8% | 5.9% | 6.3% |
| Net Income (GAAP) | $4.4K | $4.1K | $4.3K |
| EBITDA (Normalized) | $8.87B | $8.38B | $8.72B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $8.93B | $7.04B | $8.31B |
| Capital Expenditures (CapEx) | $4.26B | $3.96B | $3.95B |
| Free Cash Flow (FCF) | $4.66B | $3.08B | $4.37B |
| FCF Margin % | 4.9% | 3.5% | 5.0% |
| Return on Invested Capital (ROIC %) | 10.2% | 9.9% | 6.9% |
| Cash & Short-Term Equivalents | $6.57B | $5.03B | — |
| Total Debt (Short + Long Term) | $20.87B | $20.00B | $24.62B |
| Total Stockholders' Equity | $28.14B | $26.46B | $50.51B |